Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity. - Wikidata - wikimedia - TriplyDB

Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.

Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.

http://www.wikidata.org/entity/Q34287799

about

Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity PIASy-mediated sumoylation of SREBP1c regulates hepatic lipid metabolism upon fasting signaling T0901317 inhibits cisplatin-induced apoptosis in ovarian cancer cells [corrected]AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity.Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.Cytosolic sulfotransferase 2B1b promotes hepatocyte proliferation gene expression in vivo and in vitro.Cholesterol metabolite, 5-cholesten-3β-25-diol-3-sulfate, promotes hepatic proliferation in mice.SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding.CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer.Sulfation of 25-hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation.Biological roles of liver X receptors in immune cells.RNF20 Suppresses Tumorigenesis by Inhibiting SREBP1c-PTTG1 Axis in Kidney Cancer.The emerging roles of liver X receptors and their ligands in cancer.LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.Activation of liver X receptors suppresses inflammatory gene expressions and transcriptional corepressor clearance in rheumatoid arthritis fibroblast like synoviocytes.The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis.Systems Analysis of the Complement-Induced Priming Phase of Liver Regeneration.Snail mediates crosstalk between TGFβ and LXRα in hepatocellular carcinoma.Liver X receptors as potential targets for cancer therapeutics.The impact of 27-hydroxycholesterol on endometrial cancer proliferation.

P2860

Q27013011-19B17FF0-89E2-47F1-AAD2-4DAE1F5329E5 Q28587145-21BCBBF9-119D-4458-9B0F-2D26330E8166 Q35464846-9587B43D-7FBD-4857-B35A-A4BADE14471D Q36020243-28D3EE15-4E6B-4AA4-85BC-E8356B6CC2F3 Q36094534-553889A1-7D70-4A0A-B51C-BBFCB3838FF1 Q36175918-B375873D-3618-4CC7-B280-442340CE4B36 Q36295627-80652DE1-6EF2-447C-97B0-1C73F580733D Q37099495-42390ACB-AFCF-4E73-A6BF-70B03A0E406C Q37176588-730BB332-B04D-4B14-B99F-6F9AC76BF0B7 Q37575402-25AE916E-14C6-4F54-A388-F1B9E34DDC95 Q38018555-708FEF56-B037-47F0-8A41-5E22710AD64C Q38639202-047DE113-2726-4C76-8314-C964396BD5DB Q38703765-2D3768E2-3D1F-4D72-84C8-4F3FA0E127FA Q39133022-835D1E69-7152-404C-8E76-21974BCE761F Q39276040-F8D31A58-5A94-4469-9DBA-7AD1CEE1ADC2 Q39896001-96CCDB41-7FDC-4FCF-B8F4-E4EA71D8439E Q41198784-7EE41CDE-F530-4A25-B857-3FEE7486281A Q46243388-127DE2FB-F21B-48F3-94CD-CA5C160B7D93 Q47155172-6F38E3B4-B76D-496A-AD57-0A1BE8CB0185 Q49681806-29AD78DE-B270-4E18-9E26-1A08960F20EE

P2860

Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.

http://www.wikidata.org/entity/Q34287799

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Inhibitory effect of LXR activ ...... on through lipogenic activity.

@ast

Inhibitory effect of LXR activ ...... on through lipogenic activity.

@en

Inhibitory effect of LXR activ ...... on through lipogenic activity.

@nl

type

label

Inhibitory effect of LXR activ ...... on through lipogenic activity.

@ast

Inhibitory effect of LXR activ ...... on through lipogenic activity.

@en

Inhibitory effect of LXR activ ...... on through lipogenic activity.

@nl

prefLabel

Inhibitory effect of LXR activ ...... on through lipogenic activity.

@ast

Inhibitory effect of LXR activ ...... on through lipogenic activity.

@en

Inhibitory effect of LXR activ ...... on through lipogenic activity.

@nl

P1433

Q34287799-47A1D8C9-2A62-4D08-AA5A-F346423AAE7B

P1476

Q34287799-3AA80A44-FEE5-4C68-BA1A-66DF6A8E2FA1

P2093

Q34287799-3C80F28A-899D-4DB5-BAA6-C83999DF0C31

Q34287799-4BBA0388-E139-4E43-A0AE-CEE91E032CC0

Q34287799-6AF2C5EB-4954-49C1-A436-B3AAF07D3F04

Q34287799-6B208EBB-A537-4391-AC21-C0D52E32E5E0

Q34287799-B4063C87-C20C-41FA-8585-697A8E9F5A1C

Q34287799-F22645E3-0332-4AA0-AF5F-FB9ACE113C1A

P2860

Q34287799-090FD3DD-5CB9-42D9-99A0-C6B0DB61B581

Q34287799-0FD10CF2-816F-470D-8684-25805BBE75A4

Q34287799-173630AA-BA38-4F2C-813D-F49E7AF53747

Q34287799-1B906DD0-D7F0-4D6B-AC5F-B37820D356AE

Q34287799-206AD133-1D44-42CA-8F64-C14F45B52A52

Q34287799-314D0B3B-281F-4CEA-ACD9-E3251AA6537A

Q34287799-353CC103-CC9B-413E-A751-6040920D034C

Q34287799-3611976B-795C-48D7-AD72-42DAC4665318

Q34287799-3758BD64-CB62-49CF-A855-48C4E64BCC66

Q34287799-3B5E7034-F5B1-45CB-96BA-1F53E91EE010

P304

Q34287799-1EE614C7-DC3A-424D-9637-2969F5E7B2CD

P31

Q34287799-AD7B06E1-B2DD-47FE-8304-A5438E8D3811

P356

Q34287799-F0300971-79A2-46B0-827F-6888B91D5EB1

P433

Q34287799-08A63E6C-EF24-4172-9DC1-108EB5267424

P478

Q34287799-0699C760-A81D-40E2-B6DD-B8DF6BE85D16

P577

Q34287799-9E8E80CF-0A5A-4D68-B2CF-9842F52B5416

P698

Q34287799-D7E848B0-6966-43A1-9CC8-36873F683E89

P932

Q34287799-0F6F80C6-8C84-4854-A0B0-FC3D55B5D827

P356

P1433

Journal of Lipid Research

P1476

Inhibitory effect of LXR activ ...... on through lipogenic activity.

@en

P2093

Gha Young Lee

http://www.w3.org/2001/XMLSchema#string

Jae Bum Kim

http://www.w3.org/2001/XMLSchema#string

Jong In Kim

http://www.w3.org/2001/XMLSchema#string

Joo Won Lee

http://www.w3.org/2001/XMLSchema#string

Kang Ho Kim

http://www.w3.org/2001/XMLSchema#string

Mira Ham

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter

Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells

Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

Cyclin A in cell cycle control and cancer

Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors

Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist

Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha

Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events

Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells

Modulation of liver X receptor signaling as novel therapy for prostate cancer

P304

3425-3433

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.M007989

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20847297

http://www.w3.org/2001/XMLSchema#string

P932

2975714

http://www.w3.org/2001/XMLSchema#string